Alzheimer’s drug trial yields ‘disappointing’ results
By Andrew Jones | February 3A recent study co-led by Professor of Neurology Stephen Salloway found that bapineuzumab, a drug previously thought to slow the effects of Alzheimer’s disease, causes no improvement in patients’ memories or daily functioning. The primary clinical results were “disappointing” because positive ...